These findings demonstrated that AQP3 knockdown can inhibit proliferation and lead to cell-cycle arrest in LPS-treated cells, indicating its potential as a therapeutic target for HCC treatment. This evidence concerns the gene AQP3 and hepatocellular carcinoma.